Kathy Zhang

1.9k total citations · 1 hit paper
40 papers, 1.3k citations indexed

About

Kathy Zhang is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kathy Zhang has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kathy Zhang's work include Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Treatments and Mutations (6 papers) and Allergic Rhinitis and Sensitization (4 papers). Kathy Zhang is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Treatments and Mutations (6 papers) and Allergic Rhinitis and Sensitization (4 papers). Kathy Zhang collaborates with scholars based in United States, Australia and Belgium. Kathy Zhang's co-authors include Marc Peeters, Swaminathan Murugappan, Tae Won Kim, Paul Ruff, Roger Sidhu, Anne Thomas, Sergei Tjulandin, Timothy Price, Stefano Cascinu and Grettel J. Zamora-Berridi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Kathy Zhang

38 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

2014 339 citations Timothy Price, Marc Peeters et al. The Lancet Oncology profile →

Peers

Kathy Zhang

ONCOL

PRM

GENET

SURGE

PFM

Zhirui Zhou China

Markus Raderer Austria

Hongqing Zhuang China

Marie Kostine France

Peng Sun China

Vassilis Golfinopoulos Belgium

Rakesh Gaur United States

Rony Benson India

Albert Attia United States

Bang‐Bin Chen Taiwan

Zhirui Zhou China

Kathy Zhang

455 ×0.8

ONCOL

333 ×1.1

PRM

126 ×0.5

GENET

344 ×1.5

SURGE

143 ×0.7

PFM

Citations per year, relative to Kathy Zhang Kathy Zhang (= 1×) peers Zhirui Zhou

Countries citing papers authored by Kathy Zhang

Since Specialization

Citations

This map shows the geographic impact of Kathy Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Zhang more than expected).

Fields of papers citing papers by Kathy Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Zhang. The network helps show where Kathy Zhang may publish in the future.

Co-authorship network of co-authors of Kathy Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Zhang. A scholar is included among the top collaborators of Kathy Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Zhang. Kathy Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Kathy, et al.. (2024). The Effects of Angiotensin II versus Norepinephrine on Pulmonary Vascular Resistance in Cardiac Surgery: Post Hoc Analysis of a Randomized Controlled Trial. Journal of Cardiothoracic and Vascular Anesthesia. 38(12). 2950–2958.

Zhang, Kathy, et al.. (2023). Hyperspectral imaging to accurately segment skin erythema and hyperpigmentation in cutaneous chronic graft‐versus‐host disease. Journal of Biophotonics. 16(7). e202300009–e202300009. 7 indexed citations

Chen, Fuyao, Arved Vain, Kathy Zhang, et al.. (2023). Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease. Archives of Dermatological Research. 315(9). 2545–2554. 7 indexed citations

Zhang, Kathy, et al.. (2023). Identifying barriers to obstructive sleep-disordered breathing care: Parental perspectives. International Journal of Pediatric Otorhinolaryngology. 171. 111621–111621.

Zhang, Kathy, et al.. (2021). Subtotal Petrosectomy with Cochlear Implantation or Osseointegrated Hearing Rehabilitation: A Single Institutional Study. Otology & Neurotology. 42(10). 1499–1506. 5 indexed citations

Lickliter, Jason D., Mark Voskoboynik, Linda Mileshkin, et al.. (2021). Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours. British Journal of Cancer. 126(4). 576–585. 8 indexed citations

Yan, Flora, Yi‐Shing Lisa Cheng, Nora Katabi, et al.. (2021). Interobserver Variation in Evaluating Perineural Invasion for Oral Squamous Cell Carcinoma: Phase 2 Survey Study. Head and Neck Pathology. 15(3). 935–944. 16 indexed citations

Ciardiello, Fortunato, Yung‐Jue Bang, Johanna C. Bendell, et al.. (2021). PARALLEL 303: Phase 2 randomized study of pamiparib vs placebo as maintenance therapy in patients (pts) with inoperable locally advanced or metastatic gastric cancer that responded to platinum-based first-line (1L) chemotherapy.. Journal of Clinical Oncology. 39(15_suppl). 3109–3109. 1 indexed citations

Zhang, Kathy, et al.. (2020). Systematic Review of Negative Pressure Pulmonary Edema in Otolaryngology Procedures. Annals of Otology Rhinology & Laryngology. 130(3). 245–253. 5 indexed citations

10.

Ward, Brittany, et al.. (2019). YouTube for Cosmetic Plastic Surgery: An Effective Patient Resource?. Aesthetic Surgery Journal. 40(5). NP314–NP319. 21 indexed citations

11.

Diao, Guoqing, Donglin Zeng, Joseph G. Ibrahim, et al.. (2017). Statistical design of noninferiority multiple region clinical trials to assess global and consistent treatment effects. Journal of Biopharmaceutical Statistics. 27(6). 933–944. 3 indexed citations

12.

Price, Timothy, Kathryn J. Newhall, Marc Peeters, et al.. (2015). Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs cetuximab (cmab) in pts with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 33(15_suppl). e14623–e14623. 2 indexed citations

13.

Price, Timothy, Marc Peeters, Tae Won Kim, et al.. (2014). Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study. The Lancet Oncology. 15(6). 569–579. 339 indexed citations breakdown →

14.

Xu, Lihui, Neeraj Kohli, Rachel Rennard, et al.. (2013). Rapid optimization and prototyping for therapeutic antibody-like molecules. mAbs. 5(2). 237–254. 21 indexed citations

15.

Crawford, Jeffrey, Paul Swanson, Paul Schwarzenberger, et al.. (2013). A Phase 2 Randomized Trial of Paclitaxel and Carboplatin with or without Panitumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(12). 1510–1518. 18 indexed citations

16.

Peeters, Marc, Jean‐Yves Douillard, Eric Van Cutsem, et al.. (2012). Mutant (MT) KRAS codon 12 and 13 alleles in patients (pts) with metastatic colorectal cancer (mCRC): Assessment as prognostic and predictive biomarkers of response to panitumumab (pmab).. Journal of Clinical Oncology. 30(4_suppl). 383–383. 8 indexed citations

17.

Cohn, Allen Lee, Pankaj Khandelwal, David A. Smith, et al.. (2011). An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 10(3). 171–177. 33 indexed citations

18.

Wu, Chi‐Yuan, Kathy Zhang, Juan José Pérez Ruixo, et al.. (2011). Immunogenicity of panitumumab in combination chemotherapy clinical trials. PubMed. 11(1). 17–17. 20 indexed citations

19.

Bailey, Steven H., Michel Saint‐Cyr, Corrine Wong, et al.. (2010). The Single Dominant Medial Row Perforator DIEP Flap in Breast Reconstruction: Three-Dimensional Perforasome and Clinical Results. Plastic & Reconstructive Surgery. 126(3). 739–751. 78 indexed citations

20.

Bailey, Steven H., Michel Saint‐Cyr, Kathy Zhang, et al.. (2010). Breast Reconstruction with the Latissimus Dorsi Flap: Womenʼs Preference for Scar Location. Plastic & Reconstructive Surgery. 126(2). 358–365. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact